Society for Endocrinology members are also members of the International Society of Endocrinology (ISE).

Register to join the ISE webinar taking place on Tuesday 26 January, at 4:00 - 5:30 PM CET, to take part in an interactive discussion with top experts. The webinar will explore the role of GLP-1 RAs in the current landscape of incretin therapies for type 2 diabetes. After the session, you will be invited to solve a CME-accredited case study on the ISE Global Education Hub, to apply what you learned. 

The webinar will consist of the following interactive parts:
• Part 1: Have diabetes goals changed? What is new and relevant to Diabetes Management – By Dr Abbas Raza (Pakistan)
• Part 2: GLP-1 Agonist: A closer look at role in Diabetes Management – by Dr David D’Alessio (USA)
• Part 3: Interactive Case (best practices/patient-centered approach) – by Dr Alvin Powers (USA)
• Part 4: Meet the Experts (Debate and Q&A)

Find out more and register.

Read ISE's latest newsletter.